Isocitrate dehydrogenase mutations are rare in pheochromocytomas and paragangliomas

Keyphrases

• Pheochromocytoma 100%
• Paraganglioma 100%
• Isocitrate Dehydrogenase mutation 100%
• Von Hippel-Lindau Disease 85%
• Isocitrate Dehydrogenase 1 (IDH1) 57%
• Hypoxia-inducible Factor 42%
• Succinate Dehydrogenase 42%
• Tumor 28%
• Disease Genes 28%
• Gene mutation 28%
• Disease-related 28%
• Paraganglioma-pheochromocytoma Syndromes 28%
• Germ Cells 14%
• Tumorigenesis 14%
• Glioblastoma multiforme 14%
• Codon 14%
• Older Women 14%
• Inactivating mutation 14%
• Neuroendocrine Tumor 14%
• IDH2 mutation 14%
• Sporadic Tumors 14%
• IDH mutation 14%
• Inherited Tumor Syndromes 14%
• Succinate Dehydrogenase Gene 14%
• Carotid Body Paraganglioma 14%
• SDHAF2 14%
• Hereditary Paraganglioma 14%

Biochemistry, Genetics and Molecular Biology

• Von Hippel-Lindau Disease 100%
• Isocitrate Dehydrogenase 100%
• Succinate Dehydrogenase 66%
• Fumarate Reductase 66%
• Hypoxia-Inducible Factors 50%
• IDH1 50%
• Gene Mutation 33%
• IDH2 33%
• Germline 16%
• Germ Cell 16%
• Carcinogenesis 16%
• Enzyme 16%
• Codon 16%
• SDHB 16%
• SDHD 16%
• SDHAF2 16%

Medicine and Dentistry

• Pheochromocytoma 100%
• Paraganglioma 100%
• Isocitrate Dehydrogenase 100%
• Von Hippel-Lindau Disease 60%
• Succinate Dehydrogenase 40%
• Neoplasm 30%
• Hypoxia Inducible Factor 30%
• Gene Mutation 20%
• Somatics 20%
• Carcinogenesis 10%
• Glioblastoma 10%
• Cancer Syndrome 10%
• Codon 10%
• SDHD 10%
• Southern District Health Board 10%
• Neuroendocrine Tumor 10%
• Germ Cell 10%